INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

Showing studies that examined broccoli. Clear

People assigned to a diet, food or program and measured.

2 studies

2014 / Randomized clinical trial

Broccoli sprouts powder alone or with triple therapy eradicated H. pylori in many type 2 diabetes patients and improved some cardiovascular risk factors.

Eighty-six patients with type 2 diabetes and positive H. pylori stool antigen tests were randomized to standard triple therapy (STT) for 14 days, 6 g/d broccoli sprouts powder (BSP) for 28 days, or both (STT + BSP). H. pylori eradication rates were 89.3% in STT, 56.0% in BSP, and 91.7% in STT + BSP. Systolic and diastolic blood pressure significantly decreased in the STT + BSP group (P < 0.05), while serum triglycerides and TG/HDL-C ratio increased in the STT group (<0.05). In the BSP-only group, serum hs-CRP significantly decreased from 3.0 ± 2.5 at baseline to 2.3 ± 2.1 after treatment (P < 0.05).

Mirmiran P, Bahadoran Z, Golzarand M, et al. J Diabetes Metab Disord, 2014. PMID 24940565

2013 / Randomized controlled trial

A 12-week diet with high-glucoraphanin broccoli modulated plasma metabolite profiles and interacted with PAPOLG genotype without changing CVD risk biomarkers.

Subjects were randomly assigned to consume 400 g standard broccoli, 400 g high-glucoraphanin (HG) broccoli, or 400 g peas each week for 12 weeks. No significant differences in the effects of the diets on biomarkers of CVD risk were detected. However, univariate analysis showed significant effects of sex (P < 0.001), PAPOLG genotype (P < 0.001), and PAPOLG genotype × diet (P < 0.001) on plasma metabolic profiles. In the HG broccoli arm, the intervention reduced variation between the two PAPOLG genotypes in lipid and amino acid metabolites, tricarboxylic acid (TCA) cycle intermediates, and acylcarnitines.

Armah CN, Traka MH, Dainty JR, et al. Am J Clin Nutr, 2013. PMID 23964055